Old Web
English
Sign In
Acemap
>
Paper
>
Efficacy and Safety of Abrilumab (AMG 181/MEDI 7183) Therapy for Moderate to Severe Crohn’s Disease
Efficacy and Safety of Abrilumab (AMG 181/MEDI 7183) Therapy for Moderate to Severe Crohn’s Disease
2017
William J. Sandborn
Marcoli Cyrille
Mark Berner Hansen
Brian G. Feagan
Edward Vincent Loftus
Severine Vermeire
Martha L. Cruz
May Mo
Barbara A. Sullivan
Walter Reinisch
Keywords:
Abrilumab
Diabetes mellitus
Medicine
Crohn's disease
General surgery
Internal medicine
moderate to severe
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
7
Citations
NaN
KQI
[]